Development of a competitive direct enzyme-linked immunosorbent assay for teicoplanin

Journal of Microbiology and Biotechnology

Volumn 14, Issue 3, 2004, Pages 612-619

  Lee, Hyang B ^a   Kwak, Bo Yeon ^b   Lee, Jae Chan ^c   Kim, Chang Jin ^c   Shon, Dong Hwa ^b  

^a Seoul National University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Actinoplanes teichomyceticus; Competitive enzyme linked immunosorbent assay; Polyclonal antibody; Teicoplanin

Indexed keywords

AMOXICILLIN; ANTIGEN; BIOCHEMICAL MARKER; BOVINE SERUM ALBUMIN; ERYTHROMYCIN; HORSERADISH PEROXIDASE; LINCOMYCIN; PENICILLIN G; POLYCLONAL ANTIBODY; POLYPEPTIDE ANTIBIOTIC AGENT; RISTOCETIN; SPIRAMYCIN; TEICOPLANIN; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG CONJUGATION; DRUG CROSS REACTIVITY; DRUG DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; RABBIT; SENSITIVITY AND SPECIFICITY;

ACTINOPLANES; ACTINOPLANES TEICHOMYCETICUS; ARMORACIA RUSTICANA; BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 3342899474     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alet, P., O. Lortholary, F. Fauvelle, M. Tod, T. Genereau, M. Louchahi, A. Leon, L. Guillevin, and O. Petitjean. 1999. Pharmacokinetics of teicoplanin during plasma exchange. Clin. Microbiol. Infect. 5: 213-218.
2. Auwera, P. V., M. Aoun, and F. Meunier. 1991. Randomized study of vancomycin versus teicoplanin for the treatment of Gram positive bacterial infections in immunocompromised hosts. Antimicrob. Agents Chemother. 35: 451-457.
3. Awni, W. M., W. L. St Peter, D. R. Guay, M. T. Kenny, and G. R. Matzke. 1991. Teicoplanin measurement in patients with renal failure: Comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay. Ther. Drug Monit. 13: 511-517.
4. Bardone, M. R., M. Paternoster, and C. Coronelli. 1978. Teichomycins, new antibiotics from Actinoplanes teicomyceticus nov. sp. J. Antibiot. 31: 170-177.
5. Barna, J. C. J. and D. H. William. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu. Rev. Microbiol. 38: 339-357.
6. Bauminger, S. and M. Wilchek. 1980. The use of carbodiimides in the preparation of immunizing conjugates. Methods Enzymol. 70: 151-159.
7. Bernareggi, A., A. Borghi, M. Borgonovi, L. Cavenaghi, P. Ferrari, K. Vekey, M. Zanol, and L. F. Zerilli. 1992. Teicoplanin metabolism in humans. Antimicrob. Agents Chemother. 36: 1744-1749.
8. Bibler, M. R., T. F. Peter, D. N. Hagler, R. B. Bode, J. L. Staneck, and V. Thamlikitkul. 1987. Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious Gram-positive infections. Antimicrob. Agents Chemother. 31: 207-212.
9. Borghi A., C. Coronelli, L. Faniuolo, G. Allievi, R. Pallanza, and G. G. Gallo. 1984. Teicomycins, new antibiotics from Actinoplanes teicomyceticus nov. sp. IV. Separation and characterization of the components of teicomycin (teicoplanin). J. Antibiot. 37: 615-620.
10. Brogden, R. N., D. H. Peters, R. N. Brogden, and D. H. Peters. 1994. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47: 823-854.
11. Cavenaghi, L., A. Corti, and G. Cassani. 1986. Comparison of the solid-phase enzyme-receptor assay (SPERA) and the microbiological assay for teicoplanin. J. Hosp. Infect. 7: 85-89.
12. Corti, A., L. Cavenaghi, E. Giani, and G. Cassani. 1987. A receptor-antibody sandwich assay for teicoplanin. Clin. Chem. 33: 1615-1618.
13. Corti, A., C. Rurali, A. Borghi, and G. Cassani. 1985. Solid-phase enzyme-receptor assay (SPERA): A competitive binding assay for antibiotics of the vancomycin class. Clin. Chem. 31: 1606-1610.
14. Coutant, J. E., T. M. Chen, and B. L. Ackermann. 1990. Interfacing microbore and capillary liquid chromatography to continuous-flow fast atom bombardment mass spectrometry for the analysis of glycopeptides. J. Chromatogr. 529: 265-275.
15. Cox, H., M. Whitby, G. Nimmo, and G. Williams. 1993. Evaluation of a novel fluorescence polarization immunoassay for teicoplanin. Antimicrob. Agents Chemother. 37: 1924-1926.
16. Eremin, S. A. and D. S. Smith. 2003. Fluorescence polarization immunoassay for pesticides. Comb. Chem. High Throughput Screen 6: 257-266.
17. Falcoz, C., N. Ferry, N. Pozet, G. Cuisinaud, P. Y. Zech, and J. Sassard. 1987. Pharmacokinetics of teicoplanin in renal failure. Antimicrob. Agents Chemother. 31: 1255-1262.
18. Goldstein, F. W., A. Coutrot, A. Sieffer, and J. F. Acor. 1990. Percentages and distribution of teicoplanin and vancomycin resistant strains among coagulase negative Staphylococci. Antimicrob. Agents Chemother. 34: 899-900.
19. 13C NMR. J. Biol. Chem. 275: 6201-6206.
20. Joos, B. and R. Luthy. 1987. Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography. Antimicrob. Agents Chemother. 31: 1222-1224.
21. Jun, D. Y., S. W. Rue, B. W. Kim, and Y. H. Kim. 2003. Detection of mitotic centromere-associated kinesin (MCAK) during cell cycle progression of human jurkat T cells using polyclonal antibody raised against its N-terminal region overexpressed in E. coli. J. Microbiol. Biotechnol. 13: 912-918.
22. Kureishi, A., P. J. Jewesson, K. H. Bartlett, C. D. Cole, and A. W. Chow. 1990. Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropensic patients. Antimicrob. Agents Chemother. 34: 1642-1647.
23. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
24. Lee, J. C., H. R. Park, D. J. Park, H. B. Lee, Y. B. Kim, and C. J. Kim. 2003. Improved production of teicoplanin using adsorbent resin in fermentations. Lett. Appl. Microbiol. 37: 189-274.
25. Mastin, S. H., R. L. Buck, and P. A. Mueggler. 1993. Performance of a fluorescence polarization immunoassay for teicoplanin in serum. Diagn. Microbiol. Infect. Dis. 16: 17-24.
26. McCann, S. J., L. O. White, and B. Keevil. 2002. Assay of teicoplanin in serum: Comparison of high-performance liquid chromatography and fluorescence polarization immunoassay. J. Antimicrob. Chemother. 50: 107-110.
27. McMullin, C. M., L. O. White, A. P. MacGowan, H. A. Holt, A. M. Lovering, and D. S. Reeves. 1994. Assay of serum teicoplanin concentrations in clinical specimens: A comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay. J. Antimicrob. Chemother. 34: 425-429.
28. Mastin, S. H., R. L. Buck, and P. A. Mueggler. 1993. Performance of a fluorescence polarization immunoassay for teicoplanin in serum. Diagn. Microbiol. Infect. Dis. 16: 17-24.
29. Munro, A. J., J. Landon, and E. J. Shaw. 1982. The basis of immunoassay for antibiotics. J. Antimicrob. Chemother. 9: 423-432.
30. Parenti, F., G. Beretta, M. Berti, and V. Arioli. 1978. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties. J. Antibiot. 31: 276-283.
31. Pea, F., L. Brollo, P. Viale, F. Pavan, and M. Furlanut. 2003. Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose. J. Antimicrob. Chemother. 51: 971-975.
32. Reynolds, P. E. 1989. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8: 943-950.
33. Riva, E., N. Ferry, A. Cometti, G. Cuisinaud, G. G. Gallo, and J. Sassard. 1987. Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high-performance liquid chromatography. J. Chromatogr. 421: 99-110.
34. Somma, S., L. Gastaddo, and A. Corti. 1984. Teicoplanin, a new antibiotic from Actinoplanes teicomyceticus sp. nov.: Mechanism of action. Antimicrob. Agents Chemother. 26: 917-923.
35. Taylor, R. B., R. G. Reid, and I. M. Gould. 1991. Determination of teicoplanin in plasma using microbore high-performance liquid chromatography and injection-generated gradients. J. Chromatogr. 563: 451-457.
36. Williams, A. H., R. N. Gruneberg, A. Webster, and G. I. Ridgway. 1986. Teicoplanin in the treatment of infections caused by Gram-positive organisms. J. Hosp. Infect. 7: 101-103.
37. Wilson, A. P. 2000. Clinical pharmacokinetics of teicoplanin. Clin. Pharmacokinet. 39: 167-183.